• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌患者化疗反应的半自动容积测量:我们使用RECIST的误差有多大?

Semi-automatic volumetric measurement of response to chemotherapy in lung cancer patients: How wrong are we using RECIST?

作者信息

Greenberg Vladislav, Lazarev Irina, Frank Yigal, Dudnik Julia, Ariad Samuel, Shelef Ilan

机构信息

Department of Oncology, Soroka University Medical Center (SUMC) and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Department of Radiology, Soroka University Medical Center (SUMC) and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

出版信息

Lung Cancer. 2017 Jun;108:90-95. doi: 10.1016/j.lungcan.2017.02.017. Epub 2017 Mar 6.

DOI:10.1016/j.lungcan.2017.02.017
PMID:28625656
Abstract

OBJECTIVES

Lung cancer typically starts as a near-spherical lesion, but as it grows it may acquire an irregular radiologic formation. RECIST is based on the assumption that tumors are spherical, and consequently, proportional changes of tumor volume and parallel changes in tumor diameter, and vice versa. Hence, a 30% decrease in diameter (2r) implies a 65% decrease of volume, and a 20% increase in diameter implies a 73% increase of volume.

MATERIALS AND METHODS

We compared volumetric measurement based on multi-detector CT technology with calculated volume (CV) according to RECIST in a cohort of 43 patients with advanced, non-squamous cell type, lung cancer treated with a combination of platinum and pemetrexed.

RESULTS

CV was larger than SMV in most patients both at baseline and at best overall response (BOR). The difference between the sum of volumes based on volumetric measurement (SMV) and CV was larger for higher sum of diameters. The Lin's concordance correlation coefficient between the percent changes in SMV and CV at BOR was 0.757. Of note, four patients (4/43, 9.5%) were categorized as PD according to the method of CV, but SD according to the method of SMV.

CONCLUSION

Our study highlights the importance of volumetric measurement for assessing response to treatment in lung cancer patients particularly showing large, irregular lesions.

摘要

目的

肺癌通常起始为近球形病变,但随着其生长,可能会呈现不规则的放射学形态。实体瘤疗效评价标准(RECIST)基于肿瘤为球形这一假设,因此,肿瘤体积的比例变化与肿瘤直径的平行变化相互对应,反之亦然。所以,直径(2r)减小30%意味着体积减小65%,直径增加20%意味着体积增加73%。

材料与方法

我们在一组43例接受铂类和培美曲塞联合治疗的晚期非鳞状细胞型肺癌患者中,将基于多排CT技术的体积测量与根据RECIST计算的体积(CV)进行了比较。

结果

在基线和最佳总体缓解(BOR)时,大多数患者的CV均大于标准化摄取值(SMV)。直径总和越高,基于体积测量的体积总和(SMV)与CV之间的差异越大。BOR时SMV和CV百分比变化之间的Lin一致性相关系数为0.757。值得注意的是,4例患者(4/43,9.5%)根据CV方法被分类为疾病进展(PD),但根据SMV方法被分类为疾病稳定(SD)。

结论

我们的研究强调了体积测量在评估肺癌患者治疗反应中的重要性,尤其是对于表现为大的、不规则病变的患者。

相似文献

1
Semi-automatic volumetric measurement of response to chemotherapy in lung cancer patients: How wrong are we using RECIST?肺癌患者化疗反应的半自动容积测量:我们使用RECIST的误差有多大?
Lung Cancer. 2017 Jun;108:90-95. doi: 10.1016/j.lungcan.2017.02.017. Epub 2017 Mar 6.
2
Assessing response to treatment in non--small-cell lung cancer: role of tumor volume evaluated by computed tomography.评估非小细胞肺癌的治疗反应:计算机断层扫描评估肿瘤体积的作用
Clin Lung Cancer. 2014 Mar;15(2):103-9. doi: 10.1016/j.cllc.2013.11.001. Epub 2013 Nov 13.
3
Tumor response assessment by measuring the single largest lesion per organ in patients with advanced non-small cell lung cancer.通过测量晚期非小细胞肺癌患者每个器官中单个最大病灶来评估肿瘤反应。
Lung Cancer. 2014 Sep;85(3):385-9. doi: 10.1016/j.lungcan.2014.07.008. Epub 2014 Jul 17.
4
Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.肿瘤生长动力学与实体瘤疗效评价标准对比以评估乳腺癌肝转移局部区域治疗的反应
Acad Radiol. 2014 Aug;21(8):950-7. doi: 10.1016/j.acra.2014.02.015. Epub 2014 May 13.
5
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.在非小细胞肺癌患者中,比较RECIST、EORTC标准和PERCIST用于评估化疗早期反应的情况。
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1945-53. doi: 10.1007/s00259-016-3420-7. Epub 2016 May 28.
6
CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non-small-cell Lung Cancer.CT 容积测量和基本纹理分析作为晚期非小细胞肺癌的替代标志物。
Clin Lung Cancer. 2020 May;21(3):225-231. doi: 10.1016/j.cllc.2019.08.004. Epub 2019 Oct 8.
7
Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience.常规化疗和抗血管生成化疗治疗晚期肺腺癌患者的全肿瘤灌注 CT:初步经验。
Radiology. 2011 May;259(2):574-82. doi: 10.1148/radiol.11100600. Epub 2011 Feb 25.
8
Semiautomatic Analysis on Computed Tomography in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Reproducibility and Prognostic Significance of Unidimensional and 3-dimensional Measurements.局部晚期或转移性非小细胞肺癌的计算机断层扫描半自动分析:一维和三维测量的可重复性及预后意义
J Thorac Imaging. 2015 Sep;30(5):290-9. doi: 10.1097/RTI.0000000000000145.
9
Comparison of CT volumetric measurement with RECIST response in patients with lung cancer.肺癌患者CT容积测量与RECIST反应的比较。
Eur J Radiol. 2016 Mar;85(3):524-33. doi: 10.1016/j.ejrad.2015.12.019. Epub 2016 Jan 2.
10
Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?在预测未经治疗的晚期非小细胞肺癌患者的临床结局方面,基于¹⁸F-氟脱氧葡萄糖正电子发射断层扫描的代谢反应在铂类化疗两个周期后是否优于基于实体瘤疗效评价标准的反应?
Nucl Med Commun. 2011 Dec;32(12):1113-20. doi: 10.1097/MNM.0b013e32834a8341.

引用本文的文献

1
Reliability of Automated RECIST 1.1 and Volumetric RECIST Target Lesion Response Evaluation in Follow-Up CT-A Multi-Center, Multi-Observer Reading Study.自动RECIST 1.1和容积RECIST靶病灶反应评估在随访CT中的可靠性——一项多中心、多观察者阅片研究
Cancers (Basel). 2024 Nov 29;16(23):4009. doi: 10.3390/cancers16234009.
2
Clinical outcomes of hyperprogression based on volumetry in non-small cell lung cancer after immune checkpoint inhibitor treatment.免疫检查点抑制剂治疗后非小细胞肺癌中基于容积测量的超进展临床结局。
Thorac Cancer. 2022 Aug;13(15):2170-2179. doi: 10.1111/1759-7714.14539. Epub 2022 Jul 3.
3
Assessment of Solid Pulmonary Nodules or Masses Using Zero Echo Time MR Lung Imaging: A Prospective Head-to-Head Comparison With CT.
使用零回波时间磁共振肺部成像评估实性肺结节或肿块:与CT的前瞻性直接比较
Front Oncol. 2022 Apr 26;12:812014. doi: 10.3389/fonc.2022.812014. eCollection 2022.
4
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria.肾上腺皮质癌与CT对治疗反应的评估:综合多种标准的价值
Cancers (Basel). 2020 May 28;12(6):1395. doi: 10.3390/cancers12061395.
5
Evaluation of an AI-Powered Lung Nodule Algorithm for Detection and 3D Segmentation of Primary Lung Tumors.人工智能肺结节算法在原发性肺肿瘤检测和三维分割中的评估。
Contrast Media Mol Imaging. 2019 Jul 1;2019:1545747. doi: 10.1155/2019/1545747. eCollection 2019.
6
Inter-observer variability of manual contour delineation of structures in CT.CT 中手动勾画结构轮廓的观察者间变异性。
Eur Radiol. 2019 Mar;29(3):1391-1399. doi: 10.1007/s00330-018-5695-5. Epub 2018 Sep 7.